.svg)
Bronwyn has over 18 years executive experience in the health technology sector spanning commercialisation, venture capital, corporate development, capital raising and industry advocacy.
Formerly an Investment Director with leading healthcare VC, BioScience Managers, Bronwyn has managed over $65M of private and public equity capital raisings and been actively involved in over $30M of portfolio investments.
In 2017, Bronwyn founded ANDHealth, Australia’s only dedicated digital health accelerator & commercialisation support organisation. Now Australia’s leading health technology scale up accelerator, ANDHealth’s unique industry-led model has led to significant growth within Australia’s nascent digital health sector.
Bronwyn holds a number of health, technology and innovation advisory roles both in Australia and internationally. She has a Masters of Commercial Law from the University of Melbourne and a Bachelor of Commerce from the University of Western Australia. Bronwyn is Non-Executive Director and Chair of the Nomination & Remuneration Committee for Lumos Diagnostics.
Advisory roles:
• Australia New Zealand Leadership Forum Health Technologies Sector Group
• NSW Cyber Security Industry Standards Harmonisation Taskforce
• OUTBREAK Project Data Governance Advisory Committee
• RMIT University Health and BioMedical Sector Expert Research Advisory Group
• Swinburne University Innovation Precinct Advisory Board
• La Trobe University Digital Health Advisory Committee
With executive management and board level experience spanning government, commercial and academic sectors, Damien Millen brings strong management, advisory and industry sector knowledge to ANDHealth. Damien has specialised in the areas of innovation, commercialisation, law and investment. With a demonstrable track record in achieving high yield investments for government and commercial parties, Damien is recognised for providing high-quality advice to government and the sector and leading high value projects within government and industry. He has deep experience in developing and implementing complex agreements and projects on a state, national and international level and sourcing funding and development of innovative, early stage technologies. Damien has tertiary qualifications in law, biotechnology, technology management, finance and investment. He was admitted as a Legal Practitioner of the Supreme Court of NSW in 1998.
With degrees in both Chemical Engineering and Immunology from the University of Melbourne, Grace has a track record in project management, clinical validation and commercialisation within the medtech and digital health sectors. She has previously held roles in the Project Management team at CSL Group and has been involved in the creation of multiple medtech businesses in her role as Business Development Manager of Grey Innovation. Grace is a co-inventor on a now ASX listed digital health technology developed with Monash University and has been actively involved in the development of health technologies from invention, through clinical trials, to commercialisation.
Grace has a passion for the nexus of invention, opportunity and business strategy; supporting good ideas reach their audience and survive when backed by strong and sustainable business strategy
Claire holds a Bachelor of Business (Accounting) and is a member of the institute of Chartered Accountants of Australia and New Zealand and a certified member of the Governance Institute of Australia. She is an experienced finance professional with over 15 years’ experience in senior financial roles within public and private entities across biotechnology, insurance and public practice sectors, including 9+ years ASX listed company secretary experience. Claire has worked for both small and large companies, her most recent roles prior to joining Leydin Freyer being Director of Finance, Legal & HR and Company Secretary for Cogstate Limited. Her current portfolio of clients include, but are not limited to, Alcidion Limited, Invion Limited and Horizon 3 Biotech Pty Ltd.
Kim is the GM of Investment for ANDHealth, where she leads the flagship ANDHealth+ program supporting digital health companies along the journey from early product through clinical and commercial validation, reimbursement and go-to-market strategy, and scale-up. Kim brings a global track record in digital health commercialisation, innovation strategy, and digital transformation to this role.
She began her career with Braxton/ Deloitte in North America and Europe, before taking operational roles at an e-learning startup and The Body Shop, where she established the company’s first direct-to-consumer analytics and relationship management function. Kim came to healthcare in 2010 to design and deliver a novel, data-driven support program for cardiovascular patients. In 2015 she helped establish a CTO office in Silicon Valley for AstraZeneca, where she led an external innovation team that partnered with emerging technology vendors and startups to deliver more than a dozen proof-of-concept pilots, including the company's first fully virtual clinical trials. She has held local and global roles in strategy and digital innovation in the pharmaceutical industry and as an independent advisor to start-ups on go-to-market and partnering strategy.
Kim is passionate about working with multi-disciplinary teams to bring healthcare innovation to market, and to promote Australian innovation to the world.
Andrew is an experienced corporate affairs executive and senior leader who has worked in peak industry bodies and the not-for-profit sector and has specialised knowledge developing communications that create an enduring social impact.
He has a track record delivering initiatives across a breadth of different topics and audiences including farming, FMCG and social causes. Andrew has led teams to conceptualise innovative advocacy and communications solutions, including several landmark campaigns to enhance children’s wellbeing internationally and improve education about First Nations peoples in Australia.
Andrew brings to ANDHealth extensive experience in government engagement, corporate strategy, crisis management, media relations and business development. As the former Deputy CEO for the peak vegetable farming body, AUSVEG, he led industry development, scientific communications, media relations and advocacy programs representing the interests of Australian farmers for seven years. Most recently, he spent seven years working for Australia’s largest INGO, World Vision Australia, overseeing policy and advocacy programs spanning several countries. Andrew holds tertiary qualifications in Communications and Multimedia Systems and has a First Class Honours Degree of Bachelor of Communications from Monash University.
Hayley is an events and stakeholder engagement professional with over 15-years experience in the life sciences sector. During her time at AusBiotech, Australia’s biotechnology industry organisation, Hayley played an important role in investment attraction work and advocating for increased capital awareness and input into the sector through new and expanded programs.
Passionate in the areas of strategic planning, collaboration and building and maintaining valuable partnerships, Hayley has managed major international and domestic events including flagship conferences, international trade missions and investment showcases.
Hayley graduated from LaTrobe University with a Bachelor of Business, and has also previously worked at the Victorian Automobile Chamber of Commerce.
Hayley is excited to join the dynamic ANDHealth team and looks forward to working on impactful programs for the Victorian Connected Health Innovation & Commercialisation Centre (CHICC) to support digital health companies connect and communicate their capabilities through the health, industry and government ecosystem.
Adam brings a wealth of knowledge to the ANDHealth team. He combines clinical and commercial understanding to deliver cutting-edge products to market. Adam has delivered projects in many areas of the health value chain – from development, regulation, commercialisation strategy, investment, and launch for both pharma and digital health assets. He is leading and influencing Australian healthcare by engaging across various levels of the sector, providing real insight and facilitating effective business partnering – including in his new role as Executive in Residence at ANDHealth+.
Duane has a diverse and distinctive career spanning Board, C-suite and senior executive positions in the public & private sectors primarily within the health industry. He has worked across a variety of settings including: ASX listed, private, Big 4 consulting, Fortune 200, public hospitals and the not-for-profit sectors.
In recent years Duane turned entrepreneur, establishing Potential(x) as an investment and operating company. He successfully raised capital and completed an acquisition of a unique and complex data analytics business, before leading the organisation through transformation and international expansion. In 2021 he led Potential(x) through a merger and integration with ASX-listed Beamtree, taking stewardship of 90% of the combined entity.
In addition Duane has been mentor, facilitator and investor in early stage start-ups, including programs and coaching with ANDHealth, Cicada Innovations, LaunchVic and the Melbourne Health Accelerator.
An unashamed ‘generalist’ with incurable curiosity and a drive to improve things, Duane has expertise and capability across: strategy design; commercial, marketing and service planning; leadership development; change management; product design & innovation; data analytics; corporate transactions and Web3.0 projects.
He currently provides expertise and support to organisations and leaders seeking to achieve clarity of purpose, strategic growth or digital transformation - including in his new role as ACTIVATE's Executive in Residence.
Amabel has a depth of experience across the medical research and biopharma space, from pre-clinical R&D through to supporting commercialisation with business intelligence and analyst insights. She has led proposal support at the University of Melbourne to growth the pipeline of MRFF submissions to secure revenue and funding success for impact-driven programs. Previously as a consultant at Clarivate Analytics she supported the growth of the life sciences business in ANZ with custom projects, presales engagement and professional training and workshops to support business intelligence and regulatory compliance, Amabel has hands-on R&D experience, with a PhD in vaccine design she has developed several novel vaccines and immunostimulatory agents and is a inventor for a anti-viral under commercial development. As a scientist for a University spin-out she project managed global studies for a new investigational oncology vaccine for a first in man phase 1 clinical trials.
Originally from Wellington, New Zealand, Henry is an ex-management consultant with experience developing strategies for public and private healthcare sector entities, from private hospitals to government agencies. Henry has supported large scale health and public sector reform projects including New Zealand’s COVID-19 contact tracing solution, geographic expansion strategies for a private speciality oncology hospital, the expansion of public digital identity services and the implementation of New Zealand's largest technology investment, Inland Revenue's Business Transformation programme.
Henry has tertiary qualifications in Law and Political Science and is a qualified Human Centred Design practitioner. He was admitted as a Barrister and Solicitor of the High Court of New Zealand in 2020.
Numa graduated from Monash University with a Bachelor of Science - Global Challenges (Hons) majoring in Genetics. Whilst working at a CRO as a clinical trial coordinator, Numa gained an insight into the world of clinical trials and invaluable experience in project management and stakeholder liaison. Numa has also gained experience working in, and working with start-up companies from her university days, when she founded a company with the goal to eliminate plastic pollution brought about by sanitary pads.
Numa is deeply interested in emerging technologies and the role these technologies can play in bettering the lives of others.
Max is passionate about the intersection of biomedicine, technology and finance. As Lead Analyst, Max works cross-functionally across the business to uncover industry insights used to position ANDHealth as a leader in the digital health ecosystem. Max also supports the evaluation of digital health companies and is a member of the ANDHealth+ team responsible for deploying MRFF funding to SMEs through the non-dilutive investment program ANDHealth+. Prior to ANDHealth, Max worked at CSIRO Futures, CSIRO’s strategic advisory arm, where he was responsible for translating emerging scientific trends into strategic insights for industry and government clients spanning Health & Biosecurity, Future Industries and Energy & Resources. Max holds a Bachelor of Biomedicine (Biotechnology major) from University of Melbourne.
Kate has a Bachelor of Science (Nutrition) from the University of Wollongong, as well as a PRINCE2 qualification in project management. Kate has proven abilities to coordinate and support large-scale digital health projects, with strong operational and project management experience within the healthcare sector, both in Australia and the UK. Prior to joining ANDHealth, Kate worked as a Senior Project Support Officer for DigitalHealth.London in the UK, an accelerator program aimed at connecting and supporting NHS staff, digital health companies and academics to improve healthcare through digital technology. Kate has also worked as a Nutrition Assistant at St Vincent's Hospital, Sydney. Kate is extremely passionate about improving healthcare delivery and accessibility, and believes that digital health and innovation are essential in achieving this outcome.
With a degree in Health Sciences majoring in Health Promotion and Nutrition, Tayla has experience working in digital health, the start-up ecosystem and across Public Health both in Australia and the UK. Tayla has a strong passion for program management and Community and Industry engagement.
Tayla is the Program Director - Pipeline Programs at ANDHealth. Tayla has been at ANDHealth for the last two years working closely with the VP Program Design to achieve ANDHealth's program activities, events and communications.
Tayla is profoundly passionate about helping others which is shown in her commitment to voluntary roles and wants to create a career that has a strong positive impact on others.
Dee joins ANDHealth from London, England where she has extensive national and international experience bringing health technology innovations into practice. As Head of AI Implementation for London-based start-up, Kheiron Medical Technologies, Dee spearheaded one of the first wide-scale deployments of AI in the UK’s National Health Service (NHS). Dee has been actively involved across the entire life cycle of deep-learning software medical devices from product development and evaluation, to the digital transformation of clinical services, and the real-world monitoring of AI performance. Prior to joining Kheiron, Dee was a founding team member of the DigitalHealth.London Accelerator programme which supports the spread and adoption of high-potential digital health technologies to solve health and social care challenges.
Laura has developed a deep interest in health after conquering several health-related difficulties as a child. Studying business administration taught her to understand business perspectives and gain a holistic approach. By combining her personal motivation for change in healthcare and her understanding of economics, she found her passion and calling in digital health.
Born in Melbourne but raised in Germany, Laura has recently moved back to Australia and is excited to bring her unique international experience to ANDHealth.
Alo is a Master of Biomedical Engineering student at the University of Melbourne, holding a Bachelor of Biomedicine. She enjoys connecting with others and learning as much as possible behind the scenes. With experience from Agilent Technologies and the ARC OPTIMA Training centre, as well as the Founder Institute, she is excited to contribute her skills to the digital health sector and support founders in improving the accessibility and reliability of healthcare.
Bianca holds a Bachelor of Design (Visual Communication) and a Graduate Certificate in Marketing. She has previously worked in the publishing and toy industries, where her favourite projects were educational products for children with a focus on making learning fun. Bianca loves finding creative ways to solve problems visually and teaching herself new skills.
Makie is a marketer and data enthusiast who is passionate about health and health promotion. She has over eight years of experience in marketing, business intelligence and market research in Australia and Colombia.
Her background includes the Executive Communications Advisor role at the Victorian Health Promotion Foundation (VicHealth), the Marketing Product Manager role at Falabella, the biggest retail company in South America, as well as the Marketing Coordinator role at B Lab Australia & New Zealand, a nonprofit network that works to transform the global economy to benefit all people, communities, and the planet.
Makie holds a Master of Environment with a focus on Public Health from The University of Melbourne and is an Industrial Engineer from Universidad de Los Andes in Bogotá, Colombia.
Rita is a highly organised and efficient Executive Assistant with over 10 years experience across a variety of industries including travel, consulting and health. She is a native German speaker and fluent in French. Rita also has a background in Business Administration and Office Management.
.svg)
Gavin has played a leading role in MedicalDevices across Australia, NZ and Asia Pacific for 35 years. He is driven to improve people’s health by building businesses and organisations for the benefit of all. With an extensive background as a senior commercial and executive leader in the Asia Pacific region Gavin has a track record of leading organisational growth and transformation in large and complex multinational companies, which operate in sophisticated and highly regulated markets. He is best known for developing and exporting outstanding leaders, building truly inclusive and diverse workforces and growing engaged cultures. Gavin’s philosophy of collaboration and service extends to the broader community as a passionate advocate for efforts that improve health, literacy and education, particularly for Indigenous communities. Gavin is currently CEO of Omnigon, a private Australian company in the Ostomy Care market. He is also Chair of AND Health, Australia’s Digital Health accelerator, Australian Co-Chair of the Health Technology Sector Group of the Australia/NZ Leadership Forum, Board Director for Bowel Cancer Australia andBoard Director for SAN Foundation. Gavin is a proud member of the Champions ofChange Coalition Health group, sits on SBE Life Sciences Council and serves asan Ambassador for Rotary Oceania Medical Aid for Children (ROMAC). PreviouslyGavin was Managing Director of Johnson & Johnson Medical Devices forAustralia/NZ, Chair of the Medical Technology Association of Australia, Governorof American Chamber of Commerce and Co-Founder/Chair of Macquarie Park BusinessCoalition (in partnership with United Way).
Bronwyn has over 18 years executive experience in the health technology sector spanning commercialisation, venture capital, corporate development, capital raising and industry advocacy.
Formerly an Investment Director with leading healthcare VC, BioScience Managers, Bronwyn has managed over $65M of private and public equity capital raisings and been actively involved in over $30M of portfolio investments.
In 2017, Bronwyn founded ANDHealth, Australia’s only dedicated digital health accelerator & commercialisation support organisation. Now Australia’s leading health technology scale up accelerator, ANDHealth’s unique industry-led model has led to significant growth within Australia’s nascent digital health sector.
Bronwyn holds a number of health, technology and innovation advisory roles both in Australia and internationally. She has a Masters of Commercial Law from the University of Melbourne and a Bachelor of Commerce from the University of Western Australia. Bronwyn is Non-Executive Director and Chair of the Nomination & Remuneration Committee for Lumos Diagnostics.
Advisory roles:
• Australia New Zealand Leadership Forum Health Technologies Sector Group
• NSW Cyber Security Industry Standards Harmonisation Taskforce
• OUTBREAK Project Data Governance Advisory Committee
• RMIT University Health and BioMedical Sector Expert Research Advisory Group
• Swinburne University Innovation Precinct Advisory Board
• La Trobe University Digital Health Advisory Committee
Charlie is an investor, adviser, and entrepreneur in the areas of innovation, science, research and commercialisation. He has over 20 years’ experience working in commercial, academic, and policy settings, and has been invited to speak at conferences in this field in the US, Europe and Asia. Until early 2020, Charlie was the inaugural permanent CEO of the Office of Innovation and Science Australia (now the Office of Industry, Innovation and Science Australia), a role which supported the ISABoard in delivering its mandate to provide strategic advice, program oversight and public advocacy for Australia’s Science and Innovation system. Charlie has a longstanding interest in the creation of new technology-based ventures, having previously been a member of the Investment Committee of the Venture Capital fund Uniseed, and more recently a co-founder of the Melbourne Accelerator Program. He serves on the investment committee for the commercialisation fund of the Murdoch Childrens’ Research Institute and is a mentor and investor at Moonshot Space Accelerator.
Kate Quirke has more than 25 years’ experience in the healthcare information sector. Her background includes senior management roles with several global healthcare software firms. Kate’s experience includes product management, operations delivery and business development, including having developed international markets for Australian developed software.
As Group Managing Director of Alcidion, Kate leads the various elements of the business with a particular focus on sales and marketing and developing business relationships with customers and partners across the world. She is also one of a small number of female CEOs of an ASX listed health technology company, giving her a unique view into the later stage capital markets facing ANDHealth’s program participants.
Melanie Leydin holds a Bachelor of Business majoring in Accounting and Corporate Law. She is a member of the Institute of Chartered Accountants, Fellow of the Governance Institute of Australia and is a Registered Company Auditor.
She graduated from Swinburne University in 1997, became a Chartered Accountant in 1999 and since February 2000 has been the principal of Leydin Freyer. The practice provides outsourced company secretarial and accounting services to public and private companies across a host of industries including but not limited to the Resources, technology, bioscience, biotechnology and health sectors.
Melanie has over 25 years’ experience in the accounting profession and over 15 years’ experience holding Board positions including Company Secretary of ASX listed entities. She has extensive experience in relation to public company responsibilities, including ASX and ASIC compliance, control and implementation of corporate governance, statutory financial reporting, reorganisation of Companies and shareholder relations.
